Founded in 2006, ChemExpress provides CRO and CDMO services to pharmaceutical and biotech companies....
Founded in 2006, ChemExpress provides CRO and CDMO services to pharmaceutical and biotech companies. The company supports small molecules, biologics, and new modalities such as ADCs/XDCs, peptides, and PROTACs. Its capabilities cover research, development, manufacturing, and supply of regulatory starting materials, building blocks, intermediates, reference compounds, APIs, and drug products. ChemExpress supports projects from early drug discovery through process development and commercialization. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.
KEY PRODUCTS
ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.
